Exact Mass: 548.1909206

Exact Mass Matches: 548.1909206

Found 487 metabolites which its exact mass value is equals to given mass value 548.1909206, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Bruceantin

methyl (1R,2S,3R,6R,8R,13S,14R,15R,16S,17S)-3-[(E)-3,4-dimethylpent-2-enoyl]oxy-10,15,16-trihydroxy-9,13-dimethyl-4,11-dioxo-5,18-dioxapentacyclo[12.5.0.01,6.02,17.08,13]nonadec-9-ene-17-carboxylate

C28H36O11 (548.2257506)

Bruceantin is a triterpenoid. Bruceantin is a natural product found in Brucea javanica and Brucea antidysenterica with data available. Bruceantin is a triterpene quassinoid antineoplastic antibiotic isolated from the plant Brucea antidysenterica. Bruceantin inhibits the peptidyl transferase elongation reaction, resulting in decreased protein and DNA synthesis. Bruceantin also has antiamoebic and antimalarial activity. (NCI04) C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C1974 - Quassinoid Agent C784 - Protein Synthesis Inhibitor C1907 - Drug, Natural Product Bruceantin (NSC165563) can be extracted from B. javanica and has inhibitory effects on B16 melanoma, colon cancer 38, L1210 and leukemia P388. Bruceantin (NSC165563) can be extracted from B. javanica and has inhibitory effects on B16 melanoma, colon cancer 38, L1210 and leukemia P388.

5,7-dihydroxy-2-phenyl-8-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-(3,4,5-trihydroxyoxan-2-yl)-4H-chromen-4-one

C26H28O13 (548.1529838)

(1-((2-Methoxy-4-(((phenylsulfonyl)amino)carbonyl)phenyl)methyl)-1H-indazol-6-yl)carbamic acid cyclopentyl ester

Carbamic acid, (1-((2-methoxy-4-(((phenylsulfonyl)amino)carbonyl)phenyl)methyl)-1H-indazol-6-yl)-, cyclopentyl ester

C28H28N4O6S (548.1729468000001)

1,2-Bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester

2-({2-[(acetyloxy)methoxy]-2-oxoethyl}[2-(2-{2-[bis(carboxymethyl)amino]phenoxy}ethoxy)phenyl]amino)acetic acid

C25H28N2O12 (548.1642168000001)

Carboxydextran

3,4,5,6-tetrahydroxy-2-oxo-7-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}heptanoic acid

C19H32O18 (548.1588572)

Hippurate nitrogen

bis({[2-(phenylformamido)acetyl]oxy})amino 2-(phenylformamido)acetate

C27H24N4O9 (548.1543214)

Mirificin

8-[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]-7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one

C26H28O13 (548.1529838)

PA(2:0/PGE2)

[(2R)-3-(acetyloxy)-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propoxy]phosphonic acid

C25H41O11P (548.2386366)

PA(2:0/PGE2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGE2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin E2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGE2/2:0)

[(2R)-2-(acetyloxy)-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propoxy]phosphonic acid

C25H41O11P (548.2386366)

PA(PGE2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGE2/2:0), in particular, consists of one chain of one Prostaglandin E2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/PGD2)

[(2R)-3-(acetyloxy)-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propoxy]phosphonic acid

C25H41O11P (548.2386366)

PA(2:0/PGD2) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGD2), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin D2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(PGD2/2:0)

[(2R)-2-(acetyloxy)-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propoxy]phosphonic acid

C25H41O11P (548.2386366)

PA(PGD2/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGD2/2:0), in particular, consists of one chain of one Prostaglandin D2 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

[(2R)-3-(acetyloxy)-2-{[(5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propoxy]phosphonic acid

C25H41O11P (548.2386366)

PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Lipoxin A4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0)

[(2R)-2-(acetyloxy)-3-{[(5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoyl]oxy}propoxy]phosphonic acid

C25H41O11P (548.2386366)

PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0), in particular, consists of one chain of one Lipoxin A4 at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

Pueraria glycoside 2

7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]chromen-4-one

C26H28O13 (548.1529838)

Puerarin 6''-O-Xyloside, isolated from radix of Pueraria lobata (Willd.), possesses snti-osteoporotic and anti-tumor activity. Puerarin 6''-O-Xyloside induces the mitochondria-mediated apoptosis pathway.[1][2]. Puerarin 6''-O-Xyloside, isolated from radix of Pueraria lobata (Willd.), possesses snti-osteoporotic and anti-tumor activity. Puerarin 6''-O-Xyloside induces the mitochondria-mediated apoptosis pathway.[1][2].

Sibiricose A6

[(2S,3S,4R,5R)-4-hydroxy-2,5-bis(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-3-yl] (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

C23H32O15 (548.1741122)

Sibiricose A6 is a natural product found in Polygala arillata, Polygala karensium, and other organisms with data available.

Mirificin

8-((2S,3R,4R,5S,6R)-6-((((2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one

C26H28O13 (548.1529838)

Mirificin is a flavone C-glycoside that is 7,4-dihydroxyflavone substituted by a 6-O-[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]-beta-D-glucopyranosyl residue at position 8 via a C-glycosidic linkage. It has a role as a plant metabolite. It is a dihydroxyflavone and a flavone C-glycoside. Mirificin is a natural product found in Pueraria montana var. lobata with data available. A flavone C-glycoside that is 7,4-dihydroxyflavone substituted by a 6-O-[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]-beta-D-glucopyranosyl residue at position 8 via a C-glycosidic linkage. Mirificin (Puerarin apioside) is a isoflavone in Puerariae Lobatae Radix. Mirificin inhibits tyrosinase (TYR) with an IC50 of 12.66 μM[1]. Mirificin (Puerarin apioside) is a isoflavone in Puerariae Lobatae Radix. Mirificin inhibits tyrosinase (TYR) with an IC50 of 12.66 μM[1].

Sibiricose

[(2S,3S,4R,5R)-4-hydroxy-2,5-bis(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-3-yl] (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

C23H32O15 (548.1741122)

Sibiricose A6 is a natural product found in Polygala arillata, Polygala karensium, and other organisms with data available.

Chrysin 6-C-glucoside-8-C-alpha-L-arabinopyranoside

8-alpha-L-Arabinofuranosyl-6-beta-D-glucopyranosyl-5,7-dihydroxyflavone

C26H28O13 (548.1529838)

Neohancoside D

C23H32O15 (548.1741122)

Paratunamide D (not validated)

C26H32N2O11 (548.2006001999999)

Annotation level-3

12-O-Nortrilobine

(+)-O12-Demethyltrilobine

C34H32N2O5 (548.2311102)

Apateline

O12-Demethyltelobine

C34H32N2O5 (548.2311102)

Molludistin 2-O-xyloside

C26H28O13 (548.1529838)

Briaranolide E

C28H36O11 (548.2257506)

Tricordatine

C34H32N2O5 (548.2311102)

Pannellin 1-O-acetate

(-)-Pannellin 1-O-acetate

C30H28O10 (548.1682388)

3,7-Dihydroxy-4,5-dimethoxy-8-prenylflavan 7-O-beta-D-glucopyranoside

C28H36O11 (548.2257506)

Rubiadin primeveroside

C26H28O13 (548.1529838)

Kunzeaphlogin F

C24H36O14 (548.2104956000001)

Ambofuracin

C27H32O12 (548.1893672)

Sparanoside B

C23H32O15 (548.1741122)

Daidzein 7-O-glucoside-4-O-apioside

7,4-Dihydroxyisoflavone 7-O-glucoside-4-O-apioside

C26H28O13 (548.1529838)

Ambonin

7- [ 6- [ [ 3,4-dihydroxy-4- (hydroxymethyl) oxolan-2-yl ] oxymethyl ] -3,4,5-trihydroxyoxan-2-yl ] oxy-3- (4-hydroxyphenyl) chromen-4-one

C26H28O13 (548.1529838)

Nortrilobine

N2-Demethyltrilobine

C34H32N2O5 (548.2311102)

(2R,3R)-3,5,7,4-Tetrahydroxyflavanone 7-(6-[4-Hydroxy-2-methylenebutanoyl]glucoside)

C26H28O13 (548.1529838)

Gaertneroside

C26H28O13 (548.1529838)

Almeidein

5,4-Dihydroxy-7-methoxyflavone 6,8-di-C-arabinopyranoside

C26H28O13 (548.1529838)

BCP10902

C26H28O13 (548.1529838)

Hymenoside D

C27H32O12 (548.1893672)

Sinocrassoside D1

C26H28O13 (548.1529838)

Daphneticin 4-beta-D-glucopyranoside

C26H28O13 (548.1529838)

[3R-(3alpha,4beta,5alpha,5aalpha,6alpha,9beta,9aalpha,10R*)]-5a-[(Acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-4,5,6,9,10-pentol 5,10-diacetate 6-benzoate

C28H36O11 (548.2257506)

Pachyclavulide C

C28H36O11 (548.2257506)

FT-0775560

C23H32O15 (548.1741122)

Glabcensin R

C28H36O11 (548.2257506)

Pachyovatamine

C34H32N2O5 (548.2311102)

Thelephantin E

C33H24O8 (548.1471104)

Hymenoside C

C27H32O12 (548.1893672)

Trilobatin B

C26H28O13 (548.1529838)

Sessilifoside

C26H28O13 (548.1529838)

Mollupentin 2-O-rhamnoside

C26H28O13 (548.1529838)

Cerarvensin 2-O-rhamnoside

C26H28O13 (548.1529838)

Hemsleyanoside

5,7,4-Trihydroxyflavone 6-C-alpha-L-arabinopyranoside-4"-O-rhamnoside

C26H28O13 (548.1529838)

Isohemsleyanoside

8- [ 4-O- (6-Deoxy-alpha-L-mannopyranosyl) -alpha-L-arabinopyranosyl ] -5,7-dihydroxy-2- (4-hydroxyphenyl) -4H-1-benzopyran-4-one

C26H28O13 (548.1529838)

Asterriquinone SU-5500

C34H32N2O5 (548.2311102)

Kurramine 2beta-N-oxide

C33H28N2O6 (548.1947268)

Chrysin 6-C-alpha-L-arabinopyranoside-8-C-glucoside

C26H28O13 (548.1529838)

Kurramine 2alpha-N-oxide

C33H28N2O6 (548.1947268)

3,4-Dihydroxyrottlerin

(E) -1- [ 6- [ (3-acetyl-2,4,6-trihydroxy-5-methylphenyl) methyl ] -5,7-dihydroxy-2,2-dimethylchromen-8-yl ] -3- (3,4-dihydroxyphenyl) prop-2-en-1-one

C30H28O10 (548.1682388)

Cocsoline

2-Demethylcocsuline

C34H32N2O5 (548.2311102)

Anthraquinone base + 1O, MeOH, O-Hex-Pen

C26H28O13 (548.1529838)

Annotation level-3

(+)-Cocsoline

C34H32N2O5 (548.2311102)

4-Epigummadiol-4-O-beta-D-glucosid

C26H28O13 (548.1529838)

12-O-acetylbriviolide D

C28H36O11 (548.2257506)

Elsinochrome C

C30H28O10 (548.1682388)

C26H28O13

C26H28O13 (548.1529838)

soranjidiol 6-O-beta-primveroside|soranjidion-6-O-beta-primeveroside

C26H28O13 (548.1529838)

C28H36O11

C28H36O11 (548.2257506)

daphneticin 4-O-beta-D-glucopyranoside

C26H28O13 (548.1529838)

Teupyreinidin

C28H36O11 (548.2257506)

chloromethyl schisantherin B

C28H33ClO9 (548.1812998)

1alpha,2alpha,6beta-Triacetoxy-9alpha-benzoyloxy-8alpha,15-dihydroxydihydro-beta-agarofuran

C28H36O11 (548.2257506)

chrysophanol 8-O-xylosyl-(1<>6)-glucoside|chrysophanol 8-O-xylosyl-(1[]6)-glucoside

chrysophanol 8-O-xylosyl-(1<*>6)-glucoside|chrysophanol 8-O-xylosyl-(1[*]6)-glucoside

C26H28O13 (548.1529838)

Hexa-Ac-alpha-Pyranose-2-O-alpha-Rhamnopyranosyl-L-arabinose|Hexa-Ac-beta-Pyranose-2-O-alpha-Rhamnopyranosyl-L-arabinose

C23H32O15 (548.1741122)

Plucheoside D2

C27H32O12 (548.1893672)

Me glycoside,2,3-O-isopropylidene,tetra-Ac-4-O-alpha-D-Mannopyranosyl-L-rhamnose|Me glycoside,2,3-O-isopropylidene,tetra-Ac-4-O-beta-D-Galactopyranosyl-L-rhamnose|Me glycoside,2,3-O-isopropylidene,tetra-Ac-alphaalpha-Pyranose-4-O-beta-D-Glucopyranosyl-L-rhamnose

Me glycoside,2,3-O-isopropylidene,tetra-Ac-4-O-alpha-D-Mannopyranosyl-L-rhamnose|Me glycoside,2,3-O-isopropylidene,tetra-Ac-4-O-beta-D-Galactopyranosyl-L-rhamnose|Me glycoside,2,3-O-isopropylidene,tetra-Ac-alphaalpha-Pyranose-4-O-beta-D-Glucopyranosyl-L-rhamnose

C24H36O14 (548.2104956000001)

(5R,6S,9S,10S,12S)-15,16-epoxy-2-oxo-6-O-(beta-D-glucopyranosyl)-cleroda-3,7,13(16),14-tetraen-17,12-olid-18-oic acid methyl ester

C27H32O12 (548.1893672)

7-O-apioglucosyl-7,4-dihydroxyflavone

C26H28O13 (548.1529838)

(1alpha,11beta)-23-ethoxy-1,2,21,23-tetrahydro-1,11-dihydroxy-21-oxoobacunone|23-ethoxy-21,23-dihydro-21-oxoclausenarin

C28H36O11 (548.2257506)

1S,4S,5S,6R,7R,8R,9S,10S-9-benzoyloxy-1,6,15-triacetoxy-4,8-dihydroxy-dihydro-beta-agarofuran

C28H36O11 (548.2257506)

wenchuanensin

C27H32O12 (548.1893672)

(1S)-tetramethyl-1-O-methylnyasicoside

C28H36O11 (548.2257506)

FT-0775335

C26H28O13 (548.1529838)

1-[6-[(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethylchromen-8-yl]-3-(3,4-dihydroxyphenyl)prop-2-en-1-one

C30H28O10 (548.1682388)

Hypomycin D

C30H28O10 (548.1682388)

Hypocrellin b

C30H28O10 (548.1682388)

lysidisides C

C24H36O14 (548.2104956000001)

ARQ monoacetate

C34H32N2O5 (548.2311102)

robustolide C

C28H36O11 (548.2257506)

schoepfiajasmin H

C26H28O13 (548.1529838)

2,5-dihydroxy-4-methoxyphenanthrene 2-O-alpha-L-rhamnopyranosyl-(1-6)-beta-D-glucopyranoside

C27H32O12 (548.1893672)

SCHEMBL17867115

C26H32N2O9S (548.1828422)

4?-hydroxyisoflavone-7-O-beta-D-xylopyranosyl-(1?6)-beta-D-glucopyranoside

C26H28O13 (548.1529838)

trigohowilol F

C35H32O6 (548.2198771999999)

harperfolide

C27H32O12 (548.1893672)

JBIR-52

C27H36N2O10 (548.2369836)

Thelephantin O

C33H24O8 (548.1471104)

chrysin-3-C-alpha-arabinopyranosyl-8-C-beta-glucopyranoside

C26H28O13 (548.1529838)

Diosmetin 7-O-alpha-L-rhamnopyranosyl-(1?6)-beta-D-glucopyranoside|genipin 1-O-alpha-L-rhamnopyranosyl(1?6)-beta-D-glucopyranoside

C24H36O14 (548.2104956000001)

klymollin J

C26H41ClO10 (548.2388116000001)

1-O-trans-caffeoyl-5-O-7,8-dihydro-7alpha-methoxycaffeoylquinic acid

C26H28O13 (548.1529838)

1-O-7,8-dihydro-7alpha-methoxycaffeoyl-5-O-trans-caffeoylquinic acid

C26H28O13 (548.1529838)

kuwanol A

C34H28O7 (548.1834938)

bruceanol-F

C28H36O11 (548.2257506)

Rottlerin-3,4-Dihydroxy

C30H28O10 (548.1682388)

hypocrellin a

C30H28O10 (548.1682388)

3-chloro-4-O-demethylmicrophyllinic acid

C28H33ClO9 (548.1812998)

marinoid E

C27H32O12 (548.1893672)

Striatoside B

C27H32O12 (548.1893672)

(2-hydroxy-3-methoxy-5-allyl)phenyl beta-D-(6-O-E-sinapoyl)glucopyranoside

C27H32O12 (548.1893672)

1S,4S,5S,6R,7R,8R,9S,10S-9-benzoyloxy-6,8,15-triacetoxy-1,4-dihydroxy-dihydro-beta-agarofuran

C28H36O11 (548.2257506)

(1R,2R,3R,5Z,7S,8(17)E,9S,10S,11R,12S,14S*)-2,3,9,14-tetraacetoxy-11,12-epoxybriara-5,8(17)-dien-18-one|excavatolide S

(1R*,2R*,3R*,5Z,7S*,8(17)E,9S*,10S*,11R*,12S*,14S*)-2,3,9,14-tetraacetoxy-11,12-epoxybriara-5,8(17)-dien-18-one|excavatolide S

C28H36O11 (548.2257506)

3-O-D-Apio-beta-D-furanoside,7-O-alpha-L-rhamnopyranoside-3,4,7-Trihydroxyflavone

C26H28O13 (548.1529838)

(1R*)-1-(furan-3-yl)-2-[(6aR,7R,8S,9R,10aS)-9-(beta-D-ribo-hexopyranosyl-3-uloseoxy)-3,5,6,6a,7,8,9,10-octahydro-7,8-dimethyl-3-oxonaphtho[1,8a-c]furan-7-yl]ethyl acetate|15,16-epoxy-12alpha-O-acetylcleroda-3,13(16),14-triene-18,19-olide-7alpha-O-beta-D-ribohexo-3-ulopyranoside|splendidin C

(1R*)-1-(furan-3-yl)-2-[(6aR,7R,8S,9R,10aS)-9-(beta-D-ribo-hexopyranosyl-3-uloseoxy)-3,5,6,6a,7,8,9,10-octahydro-7,8-dimethyl-3-oxonaphtho[1,8a-c]furan-7-yl]ethyl acetate|15,16-epoxy-12alpha-O-acetylcleroda-3,13(16),14-triene-18,19-olide-7alpha-O-beta-D-ribohexo-3-ulopyranoside|splendidin C

C28H36O11 (548.2257506)

Rocaglamide derivative 10

C30H28O10 (548.1682388)

Tyr His Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]butanedioic acid

C23H28N6O10 (548.1866828)

Gly Arg Ser Asp Asp

C19H32N8O11 (548.2190442)

Chrysin 6-C-glucoside 8-C-arabinoside

C26H28O13 (548.1529838)

Chrysin 6-C-glucoside 8-C-arabinoside is a natural product found in Scutellaria baicalensis with data available. Chrysin 6-C-glucoside 8-C-arabinoside can inhibit the CGRP releasing and the activation of TRPV1 channel. Chrysin 6-C-glucoside 8-C-arabinoside can be used for anti-migraine research[1].

Chrysin 6-C-arabinoside 8-C-glucoside

5,7-dihydroxy-2-phenyl-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-6-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one

C26H28O13 (548.1529838)

Chrysin 6-C-arabinoside 8-C-glucoside is a natural product found in Scutellaria baicalensis with data available.

MaohuosideA

3,5-dihydroxy-8-(3-hydroxy-3-methylbutyl)-2-(4-methoxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one

C27H32O12 (548.1893672)

Maohuoside A, a single compound isolated from the E. koreanum that potently promotes osteogenesis. Maohuoside A enhances the osteogenesis of bone marrow-derived mesenchymal stem cells via bone morphogenetic protein (BMP) and MAPK signaling pathways[1][2]. Maohuoside A, a single compound isolated from the E. koreanum that potently promotes osteogenesis. Maohuoside A enhances the osteogenesis of bone marrow-derived mesenchymal stem cells via bone morphogenetic protein (BMP) and MAPK signaling pathways[1][2].

Sibiricose A1

[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

C23H32O15 (548.1741122)

Sibiricose A1 is a hydroxycinnamic acid. Sibiricose A1 is a natural product found in Polygala arillata, Caryopteris incana, and Polygala sibirica with data available. Sibiricose A1is an oligosaccharide ester that can be found in Polygala tenuifolia[1].

5,7-dihydroxy-2-phenyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-(3,4,5-trihydroxyoxan-2-yl)chromen-4-one

NCGC00385059-01!5,7-dihydroxy-2-phenyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-(3,4,5-trihydroxyoxan-2-yl)chromen-4-one

C26H28O13 (548.1529838)

C23H32O15_alpha-D-Glucopyranoside, 3-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-fructofuranosyl

NCGC00385084-01_C23H32O15_alpha-D-Glucopyranoside, 3-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-fructofuranosyl

C23H32O15 (548.1741122)

C23H32O15_alpha-D-Glucopyranoside, beta-D-fructofuranosyl 6-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propen-1-yl]

NCGC00385221-01_C23H32O15_alpha-D-Glucopyranoside, beta-D-fructofuranosyl 6-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1-oxo-2-propen-1-yl]-

C23H32O15 (548.1741122)

5,7-dihydroxy-2-phenyl-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-8-(3,4,5-trihydroxyoxan-2-yl)chromen-4-one

C26H28O13 (548.1529838)

[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate

C23H32O15 (548.1741122)

[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate_major

C23H32O15 (548.1741122)

Ala Ser Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C28H32N6O6 (548.2383212)

Ala Trp Ser Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanamido]-3-(1H-indol-3-yl)propanoic acid

C28H32N6O6 (548.2383212)

Ala Trp Trp Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-hydroxypropanoic acid

C28H32N6O6 (548.2383212)

Cys Thr Tyr Tyr

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C25H32N4O8S (548.1940752)

Cys Tyr Thr Tyr

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoic acid

C25H32N4O8S (548.1940752)

Cys Tyr Tyr Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanoic acid

C25H32N4O8S (548.1940752)

Asp Asp His Tyr

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C23H28N6O10 (548.1866828)

Asp Asp Asn Trp

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C23H28N6O10 (548.1866828)

Asp Asp Trp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]-3-carbamoylpropanoic acid

C23H28N6O10 (548.1866828)

Asp Asp Tyr His

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C23H28N6O10 (548.1866828)

Asp Phe His Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C24H32N6O7S (548.2053082)

Asp Phe Met His

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C24H32N6O7S (548.2053082)

Asp His Asp Tyr

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C23H28N6O10 (548.1866828)

Asp His Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C24H32N6O7S (548.2053082)

Asp His Met Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C24H32N6O7S (548.2053082)

Asp His Tyr Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C23H28N6O10 (548.1866828)

Asp Met Phe His

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C24H32N6O7S (548.2053082)

Asp Met His Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C24H32N6O7S (548.2053082)

Asp Met Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C20H36N8O8S (548.2376696)

Asp Met Arg Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C20H36N8O8S (548.2376696)

Asp Asn Asp Trp

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C23H28N6O10 (548.1866828)

Asp Asn Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C23H28N6O10 (548.1866828)

Asp Gln Met Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanoic acid

C20H36N8O8S (548.2376696)

Asp Gln Arg Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanoic acid

C20H36N8O8S (548.2376696)

Asp Gln Thr Trp

(3S)-3-amino-3-{[(1S)-3-carbamoyl-1-{[(1S,2R)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}propyl]carbamoyl}propanoic acid